Record Awaiting Appraisal

Zhelnov P. A critical appraisal of ‘Hernandez L, Kuwabara H, Shah A, Yamabe K, Burnett H, Fahrbach K, Koufopoulou M, Iwakiri R. Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan. Pharmacoeconomics. 2020 Jan;38(1):69-84. doi: 10.1007/s40273-019-00841-1. PMID: 31552601; PMCID: PMC7081652’. Zheln. 2020 Nov 18;47(1):r546d16. URI: https://zheln.com/record/2020/11/16/546/.

Zheln Review Appraisal in 10 Steps:

1. ✅ Downloaded from the PubMed Systematic Subset Daily Updates
2. 🔄 Meets Shojania & Bero 2001 True Positive Criteria for Systematic Reviews by Either Title or Abstract?
3. 🔄 Full Text or Other Reports Collected by Zheln
4. 🔄 Generates Pragmatic Evidence Directly Relevant to Evidence-Based Practice?
5. 🔄 Is Duplicate?
6. 🔄 Passed or Failed Replication?
7. 🔄 Has Critical Conduct Flaws?
8. 🔄 Liked or Disliked by Zheln?
9. 🔄 Practical Implications Summarized by Zheln
10. 🔄 Appraisal Published & Call for Crowdfunding

I have uploaded this record from PubMed but haven’t appraised it yet.

If you want me to appraise this record, I’ve got several options for you:

• Wait until I get my hands on it myself.
• Buy a subscription on Patreon, GitHub Sponsors, or Open Collective for $1 to $600 and PM me with the review request.
• Send me $1 via PayPal with this reference in the message, and I’ll happily appraise it for you.
• Contact me by email or on Twitter, Facebook, Instagram, or Telegram, and I’m sure we’ll find a way around.